Deuterated Meclizine

This invention relates to deuterated forms of meclizine, and pharmaceutically acceptable salts or hydrates thereof. This invention also provides compositions comprising a compound of this invention and the use of such compositions in methods of treating diseases and conditions that are beneficially...

Full description

Saved in:
Bibliographic Details
Main Authors Graham, Philip B, Liu, Julie F
Format Patent
LanguageEnglish
Published 26.07.2018
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:This invention relates to deuterated forms of meclizine, and pharmaceutically acceptable salts or hydrates thereof. This invention also provides compositions comprising a compound of this invention and the use of such compositions in methods of treating diseases and conditions that are beneficially treated by administering meclizine and other Constitutive Androstane Receptor agonists or FGFR3 antagonists.
Bibliography:Application Number: US201615745929